Nancy Rothwell

Nancy Rothwell

President at The University of Manchester

68 year
Commercial Services
Miscellaneous
Health Technology

Profile

Dr. Dame N.
Rothwell is a Co-Chairman at Council for Science & Technology, a President at Society of Biology, a President & Vice Chancellor at The University of Manchester and a President & Vice Chancellor at Your Manchester Fund.
She is on the Board of Directors at Avon Maitland District School Board.
She is also a Non-Executive Director at AstraZeneca, and Co-Chairman at Council for Science & Technology.
She served as President of the British Neuroscience Association, a Council Member of MRC, BBSRC and Cancer Research UK.
She also served as Chairman at The Research Defence Society, and The Wellcome Trust Ltd.
Dr. Rothwell obtained a first class degree in Physiology in 1976, a PhD in 1978 and a DSc in 1987 from the University of London.

Nancy Rothwell active positions

CompaniesPositionStart
The University of Manchester President 26/03/2013
Society of Biology President 04/01/2011
Council for Science & Technology Chairman -
President -
Director/Board Member -
All active positions of Nancy Rothwell

Former positions of Nancy Rothwell

CompaniesPositionEnd
ASTRAZENECA PLC Director/Board Member 24/04/2015
Corporate Officer/Principal -
President -
The Research Defence Society Chairman -
░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Nancy Rothwell's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nancy Rothwell's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ASTRAZENECA PLC

Health Technology

Private companies8

Miscellaneous

Miscellaneous

Commercial Services

Commercial Services

Council for Science & Technology

Society of Biology

The Research Defence Society

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Nancy Rothwell
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW